Emergent BioSolutions, Inc. (NYSE:EBS) Q2 2020 Earnings Conference Call - Final Transcript
Jul 30, 2020 • 05:00 pm ET
Ladies and gentlemen, thank you for standing by and welcome to the Emergent BioSolutions' Q2 Earnings Conference Call. [Operator Instructions]
I would now like to hand the conference to Emergent BioSolutions. Please go ahead.
Robert G. Burrows
Thank you, Joel, and good afternoon, everyone. My name is Robert Burrows, Vice President of Investor Relations for Emergent. Thank you for joining us today, as we discuss the operational and financial results for the second quarter and six months ended June 30, 2020. As is customary, today's call is open to all participants and in addition, the call is being recorded and is copyrighted by Emergent BioSolutions. The agenda for today's call will follow traditional path with prepared comments from Bob Kramer, President and Chief Executive Officer; and Rich Lindahl, Chief Financial Officer. Other members of the senior team are present and available during the Q&A session following our prepared comments.
Before beginning during today's call either on our prepared comments or the Q&A session management may make projections and other forward-looking statements related to our business, future events, our prospects or future performance. These forward-looking statements are based on our current intentions, beliefs and expectations regarding future events. We cannot guarantee that any forward-looking statement will be accurate. Investors should realize that if underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could differ materially from our expectations. Any forward-looking statement speaks only as of the date of this conference call and except as required by law, we do not undertake to update any forward-looking statement to reflect new information, events or circumstances. Investors should consider this cautionary statement, as well as the risk factors identified in our periodic reports filed with the SEC when evaluating our forward-looking statements.
During our prepared comments, as well as during the Q&A session, we may also refer to certain non-GAAP financial measures that involve adjustments to GAAP figures in order to provide greater transparency regarding Emergent's operating performance. Please refer to the tables found in today's press release regarding our use of adjusted net income, and adjusted EBITDA and the reconciliations between our GAAP financial measures and these non-GAAP financial measures.
One final housekeeping item. During the Q&A session because of the fact that we are all in separate locations and practicing the necessary social distancing, per CDC guidelines, we will have CEO, Bob Kramer, fielding all questions to begin with, and then he will verbally hand off to other members of the team for additional answers as warranted. Finally, for the benefit of those who may be listening to replay of the webcast this call was held and recorded on July 30, 2020. Since then, Emergent may have made announcements related to topics discussed during today's call. You are once again encouraged to refer to our most recent press releases and SEC filings, all of which may be found on the Investors homepage of our website.
And with that introduction, I would now like to turn the call over to my colleague, Bob Kramer.